CG&D
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cell Growth & Differentiation

Right arrow Help viewing high resolution images
Right arrow Return to article
Click on image to view larger version.



Fig. 6. Role of growth factors in the activity of bryostatin-1. U937 cells were incubated for 120 h in the absence (Control) or presence of bryostatin-1 (10-8 M) along with neutralizing antihuman GM-CSF (0.1 mg/ml) and antihuman IL-3 (0.15 mg/ml) or nonbinding isotypic control antibodies and assayed for CD11b expression (A) and clonogenic growth (B). All results represent the means of three separate experiments; bars, SE. P < 0.001 was determined by the paired Student’s ttest for the comparison of bryostatin-1 + isotypic control antibodies and bryostatin-1 + growth factor blocking antibodies for both CD11b expression (A) and clonogenic growth (B).





Right arrow Return to article


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cell Growth & Differentiation